SurgePays
SURG
#10956
Rank
A$12.5 M
Marketcap
A$0.20
Share price
-1.44%
Change (1 day)
-93.04%
Change (1 year)

P/E ratio for SurgePays (SURG)

P/E ratio as of November 2026 (TTM): -0.1142

According to SurgePays's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.114167. At the end of 2025 the company had a P/E ratio of -0.9389.

P/E ratio history for SurgePays from 2018 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-0.938926.78%
2024-0.7406-116.65%
20234.45-103.39%
2022-13118756.19%
2021-0.6958-42.74%
2020-1.22-62.42%
2019-3.23-84.71%
2018-21.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
41.7-36,645.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
30.3-26,649.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Stryker Corporation
SYK
33.6-29,532.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cooper Companies
COO
20.4-17,951.57%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
CONMED
CNMD
20.0-17,614.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
82.2-72,135.53%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.